Height is a risk factor for development of peripheral insensate neuropathy


  • Sujjay J. Resident, Department of General Medicine, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, India
  • Siva Ranganathan Green Associate Professor, Department of General Medicine, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, India
  • Mohamed Kasim A. Resident, Department of General Medicine, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, India




Diabetes Mellitus, Height, Peripheral insensate neuropathy, Peripheral neuropathy


Background: Peripheral insensate neuropathy is one of the most common and forms of peripheral neuropathy. It is a preeminent cause for disability, foot ulcers, deformity and amputations in individuals who are at risk.

Methods: A study was conducted in Mahatma Gandhi Medical College & Research Institute, Pondicherry, India in the year 2017-18, which included examination of 760 people of more than 30 years of age by random sampling method who was attending the outpatient clinic. The Semmes Weinstein monofilament was adopted to ascertain the presence of peripheral insensate neuropathy.

Results: In present study, the prevalence of peripheral insensate neuropathy was 3.2%. As the height increased, the prevalence of peripheral insensate neuropathy increased, regardless of other independent risk factors like diabetes, hypertension, etc. The risk of the peripheral insensate neuropathy increases at a height of >171.5cm in males and at a height of >164.5cm in females.

Conclusions: The authors confirm that body height is a significant and independent risk factor for peripheral insensate neuropathy, regardless of co-morbidities. Height as a guide, helps the health care professionals in identifying the people who are at risk for peripheral insensate neuropathy.


Cheng YJ, Gregg EW, Kahn HS, Williams DE, De Rekeneire N, Narayan KMV. Peripheral insensate neuropathy-a tall problem for US adults?. Am J Epidemiol. 2006;164(9):873-80.

Kote GSS, Bhat AN, KT, Ismail MH, Gupta A. peripheral insensate neuropathy-is height a risk factor?. J Clin Diagn Res. 2013;7(2):296-301.

Sorensen L, Molyneaux L, Yue DK. Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diab Res Clin Prac. 2002;57(1):45-51.

Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia. 1996;39(11):1377-84.

England JD, Asbury AK. Peripheral neuropathy. The Lancet. 2004;363(9427):2151-61.

Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia. 2000;43(8):957-73.

Ragnarson Tennvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia. 2001;44(11):2077-87.

Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-28.

Sullivan K, Feldman E. New developments in diabetic neuropathy. Current Opinion Neurol. 2005;18(5):586-90.

Herman WH, Kennedy L, for the GOAL A1C Study Group. Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabetes Care. 2005;28(6):1480-81.

Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract. 2000;49(11):S17-29.

Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care. 1998;21(12):2161-77.

Mcgill M, Molyneaux L, Spencer R, Heng LF, Yue DK. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes care. 1999;22(4):598-602.

Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The north-west diabetes foot care study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377-84.

Tseng CH. Prevalence of lower-extremity amputation among patients with diabetes mellitus: Is height a factor? CMAJ. 2006;174(3):319-23.

Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, et al. Prevalence of lower-extremity disease in the U.S. adult population ≥40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(7):1591-97.

Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes care. 2004 Jun 1;27(6):1458-86.

Dinh T, Veves A. The influence of gender as a risk factor in diabetic foot ulceration. Wounds. 2008;20(5):127-31.

Huang CR, Chang WN, Chang HW, Tsai NW, Lu CH. Effects of age, gender, height, and weight on late responses and nerve conduction study parameters. Acta Neurol Taiwan. 2009;18(4):242-49.

Chu NS. Somatosensory evoked potentials: Correlations with height. Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section. 1986;65(3):169-76.

Jameson JL. Harrison’s Principles of Internal Medicine. 20th ed. New York: McGraw-Hill Education; 2018.

Tesfaye S, Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy?. Curr Diab Rep. 2009;9(6):432-4.

Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. New England J Med. 1995 Jul 13;333(2):89-94.

Vinik AI. Diabetic sensory and motor neuropathy. New England J Med. 2016;374(15):1455-64.

Gregg EW, Li Y, Wang J, Rios Burrows N, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. New England J Med.. 2014;370(16):1514-23.

Nisar MU, Asad A, Waqas A, Ali N, Nisar A, Qayyum MA, et al. Association of diabetic neuropathy with duration of type 2 diabetes and glycemic control. Cureus. 2015 Aug;7(8).

Pop-Busui R, Lu J, Brooks MM, Albert S, Althouse AD, Escobedo J, et al. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) Cohort. Diabetes Care. 2013;36(10):3208-15.

Ang L, Jaiswal M, Martin C, Pop-Busui R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep. 2014;14(9):528.

Jarmuzewska EA, Ghidoni A, Mangoni AA. Hypertension and sensorimotor peripheral neuropathy in type 2 diabetes. ENE. 2007;57(2):91-5.

Forrest KYZ, Maser RE, Pambianco G, Becker DJ, Orchard TJ. Hypertension as a risk FACTOR for diabetic neuropathy: A prospective study. Diabetes. 1997;46(4):665-70.

Group BMJP. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-13.

Callaghan BC, Viswanathan V, Reynolds EL, Feldman EL. The metabolic drivers of neuropathy in India. Diabetes. 2018;67(1):2207-PUB.

Liu X, Xu Y, An M, Zeng Q. The risk factors for diabetic peripheral neuropathy: A meta-analysis. PloS one. 2019 Feb 20;14(2):e0212574.

Sosenko JM, Gadia MT, Fournier AM, O’Connell MT, Aguiar MC, Skyler JS. Body stature as a risk factor for diabetic sensory neuropathy. Am J Med. 1986;80(6):1031-34.

Robinson LR, Stolov WC, Rubner DE, Wahl PW, Leonetti DL, Fujimoto WY. Height is an independent risk factor for neuropathy in diabetic men. Diabetes Res Clin Pract. 1992;16(2):97-102.

Barrenäs ML, Jonsson B, Tuvemo T, Hellström PA, Lundgren M. High risk of sensorineural hearing loss in men born small for gestational age with and without obesity or height catch-up growth: a prospective longitudinal register study on birth size in 245,000 Swedish conscripts. J Clin Endocrinol Metab. 2005;90(8):4452-56.

Iversen MM, Midthjell K, Østbye T, Tell GS, Clipp E, Sloane R, et al. History of and factors associated with diabetic foot ulcers in Norway: the Nord-Trøndelag Health Study. Scandinavian J Pub Heal. 2008;36(1):62-8.

Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain. 2004;127(7):1606-15.

Clair C, Cohen MJ, Eichler F, Selby KJ, Rigotti NA. The effect of cigarette smoking on diabetic peripheral neuropathy: a systematic review and meta-analysis. J Gen Intern Med. 2015;30(8):1193-203.

Julian T, Glascow N, Syeed R, Zis P. Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. J Neurol. 2018 Nov 22:1-3.






Original Research Articles